Skip to main content
Top
Published in: Journal of Neuroinflammation 1/2013

Open Access 01-12-2013 | Research

Amyloid-β peptide-induced extracellular S100A9 depletion is associated with decrease of antimicrobial peptide activity in human THP-1 monocytes

Authors: Eun Ok Lee, Ji Hye Yang, Keun-A Chang, Yoo-Hun Suh, Young Hae Chong

Published in: Journal of Neuroinflammation | Issue 1/2013

Login to get access

Abstract

Background

S100A9 protein (myeloid-related protein MRP14, also referred to as calgranulin B) is a reliable marker of inflammation, an important proinflammatory factor of innate immunity and acts as an additional antimicrobial peptide in the innate immune system. Evidence indicates that S100A9 contributes to Alzheimer’s disease (AD) pathology, although the precise mechanisms are not clear.

Methods

We were interested to study the mechanisms of S100A9 release upon Aβ1-42 stimulation, the potential roles of extracellular S100A9 depletion in Aβ-induced cytotoxicity, and the interaction with innate immune response in THP-1 monocytic cells that have been challenged with mostly Aβ1-42 monomers instead of oligomers. We used protein preparation, Ca2+ influx fluorescence imaging, MTT assay, siRNA knockdown, colony forming units (CFUs) assay and western blotting techniques to perform our study.

Results

Aβ1-42 monomers elicited a marked decrease of S100A9 release into the cell culture supernatant in a dose-dependent manner in human THP-1 monocytes. This reduction of S100A9 release was accompanied by an increase of intracellular Ca2+ level. Aβ1-42-mediated decrease of S100A9 release was not associated with Aβ1-42-induced cytotoxicity as measured by MTT reduction assay. This observation was confirmed with the recombinant S100A9, which had little effect on Aβ1-42-induced cytotoxicity. Moreover, depletion of S100A9 with siRNA did not significantly evoke the cell toxicity. On the other hand, Aβ1-42-induced extracellular S100A9 depletion resulted in decreased antimicrobial activity of the culture supernatant after Aβ1-42 stimulation. Immunodepletion of S100A9 with anti-S100A9 also decreased the antimicrobial peptide activity of the vehicle treated culture supernatant. Consistently, the recombinant S100A9 clearly elicited the antimicrobial peptide activity in vitro, confirming the observed antimicrobial activity of S100A9 in the culture supernatant.

Conclusion

Collectively, our findings suggest that the mostly monomeric form of Aβ1-42 negatively regulates the innate immune system by down-regulating the secretion of S100A9, which is likely a main mediator of antimicrobial activity in the conditioned media of human THP-1 monocytes.
Literature
1.
go back to reference Hampel H, Bürger K, Teipel SJ, Bokde AL, Zetterberg H, Blennow K: Core candidate neurochemical and imaging biomarkers of Alzheimer’s disease. Alzheimers Dement 2008, 4:38–48.CrossRefPubMed Hampel H, Bürger K, Teipel SJ, Bokde AL, Zetterberg H, Blennow K: Core candidate neurochemical and imaging biomarkers of Alzheimer’s disease. Alzheimers Dement 2008, 4:38–48.CrossRefPubMed
2.
go back to reference Chételat G, Villemagne VL, Pike KE, Ellis KA, Bourgeat P, Jones G, O’Keefe GJ, Salvado O, Szoeke C, Martins RN, Ames D, Masters CL, Rowe CC, Australian Imaging Biomarkers and Lifestyle Study of ageing (AIBL) Research Group: Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer’s disease. Brain 2011, 134:798–807.CrossRefPubMed Chételat G, Villemagne VL, Pike KE, Ellis KA, Bourgeat P, Jones G, O’Keefe GJ, Salvado O, Szoeke C, Martins RN, Ames D, Masters CL, Rowe CC, Australian Imaging Biomarkers and Lifestyle Study of ageing (AIBL) Research Group: Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer’s disease. Brain 2011, 134:798–807.CrossRefPubMed
3.
go back to reference Lukiw WJ: Amyloid beta (Aβ) peptide modulators and other current treatment strategies for Alzheimer's disease (AD). Expert Opin Emerg Drugs 2012, 17:43–60.CrossRef Lukiw WJ: Amyloid beta (Aβ) peptide modulators and other current treatment strategies for Alzheimer's disease (AD). Expert Opin Emerg Drugs 2012, 17:43–60.CrossRef
4.
go back to reference Eikelenboom P, Veerhuis R, van Exel E, Hoozemans JJ, Rozemuller AJ, van Gool WA: The early involvement of the innate immunity in the pathogenesis of late-onset Alzheimer’s disease: neuropathological, epidemiological and genetic evidence. Curr Alzheimer Res 2011, 8:142–150.CrossRefPubMed Eikelenboom P, Veerhuis R, van Exel E, Hoozemans JJ, Rozemuller AJ, van Gool WA: The early involvement of the innate immunity in the pathogenesis of late-onset Alzheimer’s disease: neuropathological, epidemiological and genetic evidence. Curr Alzheimer Res 2011, 8:142–150.CrossRefPubMed
5.
go back to reference Cribbs DH, Berchtold NC, Perreau V, Coleman PD, Rogers J, Tenner AJ, Cotman CW: Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study. J Neuroinflammation 2012, 9:179.CrossRefPubMedPubMedCentral Cribbs DH, Berchtold NC, Perreau V, Coleman PD, Rogers J, Tenner AJ, Cotman CW: Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study. J Neuroinflammation 2012, 9:179.CrossRefPubMedPubMedCentral
6.
go back to reference Butchart J, Holmes C: Systemic and central immunity in Alzheimer’s disease: therapeutic implications. CNS Neurosci Ther 2012, 18:64–76.CrossRefPubMed Butchart J, Holmes C: Systemic and central immunity in Alzheimer’s disease: therapeutic implications. CNS Neurosci Ther 2012, 18:64–76.CrossRefPubMed
7.
go back to reference Perera C, McNeil HP, Geczy CL: S100 Calgranulins in inflammatory arthritis. Immunol Cell Biol 2010, 88:41–49.CrossRefPubMed Perera C, McNeil HP, Geczy CL: S100 Calgranulins in inflammatory arthritis. Immunol Cell Biol 2010, 88:41–49.CrossRefPubMed
8.
go back to reference van Lent PL, Grevers L, Blom AB, Sloetjes A, Mort JS, Vogl T, Nacken W, van den Berg WB, Roth J: Myeloid-related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis. Ann Rheum Dis 2008, 67:1750–1758.CrossRefPubMed van Lent PL, Grevers L, Blom AB, Sloetjes A, Mort JS, Vogl T, Nacken W, van den Berg WB, Roth J: Myeloid-related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis. Ann Rheum Dis 2008, 67:1750–1758.CrossRefPubMed
9.
go back to reference Sroussi HY, Berline J, Palefsky JM: Oxidation of methionine 63 and 83 regulates the effect of S100A9 on the migration of neutrophils in vitro. J Leukoc Biol 2007, 81:818–824.CrossRefPubMed Sroussi HY, Berline J, Palefsky JM: Oxidation of methionine 63 and 83 regulates the effect of S100A9 on the migration of neutrophils in vitro. J Leukoc Biol 2007, 81:818–824.CrossRefPubMed
10.
go back to reference Sroussi HY, Lu Y, Villines D, Sun Y: The down regulation of neutrophil oxidative metabolism by S100A8 and S100A9: implication of the protease-activated receptor-2. Mol Immunol 2012, 50:42–48.CrossRefPubMed Sroussi HY, Lu Y, Villines D, Sun Y: The down regulation of neutrophil oxidative metabolism by S100A8 and S100A9: implication of the protease-activated receptor-2. Mol Immunol 2012, 50:42–48.CrossRefPubMed
11.
go back to reference Erez O, Romero R, Tarca AL, Chaiworapongsa T, Kim YM, Than NG, Vaisbuch E, Draghici S, Tromp G: Differential expression pattern of genes encoding for antimicrobial peptides in the fetal membranes of patients with spontaneous preterm labor and intact membranes and those with preterm prelabor rupture of the membranes. J Matern Fetal Neonatal Med 2009, 22:1103–1115.CrossRefPubMedPubMedCentral Erez O, Romero R, Tarca AL, Chaiworapongsa T, Kim YM, Than NG, Vaisbuch E, Draghici S, Tromp G: Differential expression pattern of genes encoding for antimicrobial peptides in the fetal membranes of patients with spontaneous preterm labor and intact membranes and those with preterm prelabor rupture of the membranes. J Matern Fetal Neonatal Med 2009, 22:1103–1115.CrossRefPubMedPubMedCentral
12.
go back to reference Hiroshima Y, Bando M, Kataoka M, Inagaki Y, Herzberg MC, Ross KF, Hosoi K, Nagata T, Kido J: Regulation of antimicrobial peptide expression in human gingival keratinocytes by interleukin-1α. Arch Oral Biol 2011, 56:761–767.CrossRefPubMedPubMedCentral Hiroshima Y, Bando M, Kataoka M, Inagaki Y, Herzberg MC, Ross KF, Hosoi K, Nagata T, Kido J: Regulation of antimicrobial peptide expression in human gingival keratinocytes by interleukin-1α. Arch Oral Biol 2011, 56:761–767.CrossRefPubMedPubMedCentral
13.
go back to reference Zimmer DB, Chaplin J, Baldwin A, Rast M: S100-mediated signal transduction in the nervous system and neurological diseases. Cell Mol Biol 2005, 51:201–214.PubMed Zimmer DB, Chaplin J, Baldwin A, Rast M: S100-mediated signal transduction in the nervous system and neurological diseases. Cell Mol Biol 2005, 51:201–214.PubMed
14.
go back to reference Postler E, Lehr A, Schluesener H, Meyermann R: Expression of the S-100 proteins MRP-8 and −14 in ischemic brain lesions. Glia 1997, 19:27–34.CrossRefPubMed Postler E, Lehr A, Schluesener H, Meyermann R: Expression of the S-100 proteins MRP-8 and −14 in ischemic brain lesions. Glia 1997, 19:27–34.CrossRefPubMed
15.
go back to reference Engel S, Schluesener H, Mittelbronn M, Seid K, Adjodah D, Wehner HD, Meyermann R: Dynamics of microglial activation after human traumatic brain injury are revealed by delayed expression of macrophage-related proteins MRP8 and MRP14. Acta Neuropathol 2000, 100:313–322.CrossRefPubMed Engel S, Schluesener H, Mittelbronn M, Seid K, Adjodah D, Wehner HD, Meyermann R: Dynamics of microglial activation after human traumatic brain injury are revealed by delayed expression of macrophage-related proteins MRP8 and MRP14. Acta Neuropathol 2000, 100:313–322.CrossRefPubMed
16.
go back to reference Heneka MT, Wiesinger H, Dumitrescu OL, Riederer P, Feinstein DL, Klockgether T: Neuronal and glial coexpression of argininosuccinatesynthetase and inducible nitric oxide synthase in Alzheimer disease. J Neuropathol Exp Neurol 2001, 60:906–916.CrossRefPubMed Heneka MT, Wiesinger H, Dumitrescu OL, Riederer P, Feinstein DL, Klockgether T: Neuronal and glial coexpression of argininosuccinatesynthetase and inducible nitric oxide synthase in Alzheimer disease. J Neuropathol Exp Neurol 2001, 60:906–916.CrossRefPubMed
17.
go back to reference Shepherd CE, Goyette J, Utter V, Rahimi F, Yang Z, Geczy CL, Halliday GM: Inflammatory S100A9 and S100A12 proteins in Alzheimer’s disease. Neurobiol Aging 2006, 27:1554–1563.CrossRefPubMed Shepherd CE, Goyette J, Utter V, Rahimi F, Yang Z, Geczy CL, Halliday GM: Inflammatory S100A9 and S100A12 proteins in Alzheimer’s disease. Neurobiol Aging 2006, 27:1554–1563.CrossRefPubMed
18.
go back to reference Ha TY, Chang KA, Kim J, Kim HS, Kim S, Chong YH, Suh YH: S100a9 knockdown decreases the memory impairment and the neuropathology in Tg2576 mice. AD animal model. PLoS One 2010, 5:e8840.CrossRefPubMedPubMedCentral Ha TY, Chang KA, Kim J, Kim HS, Kim S, Chong YH, Suh YH: S100a9 knockdown decreases the memory impairment and the neuropathology in Tg2576 mice. AD animal model. PLoS One 2010, 5:e8840.CrossRefPubMedPubMedCentral
19.
go back to reference Chang KA, Kim HJ, Suh YH: The role of S100a9 in the pathogenesis of Alzheimer’s disease: the therapeutic effects of S100a9 knockdown or knockout. Neurodegener Dis 2012, 10:27–29.CrossRefPubMed Chang KA, Kim HJ, Suh YH: The role of S100a9 in the pathogenesis of Alzheimer’s disease: the therapeutic effects of S100a9 knockdown or knockout. Neurodegener Dis 2012, 10:27–29.CrossRefPubMed
20.
go back to reference Zhang C, Liu Y, Gilthorpe J, van der Maarel JR: MRP14 (S100A9) protein interacts with Alzheimer beta-amyloid peptide and induces its fibrillization. PLoS One 2012, 7:e32953.CrossRefPubMedPubMedCentral Zhang C, Liu Y, Gilthorpe J, van der Maarel JR: MRP14 (S100A9) protein interacts with Alzheimer beta-amyloid peptide and induces its fibrillization. PLoS One 2012, 7:e32953.CrossRefPubMedPubMedCentral
21.
go back to reference Lee EO, Kang JL, Chong YH: The amyloid-beta peptide suppresses transforming growth factor-beta1-induced matrix metalloproteinase-2 production via Smad7 expression in human monocytic THP-1 cells. J Biol Chem 2005, 280:7845–7853.CrossRefPubMed Lee EO, Kang JL, Chong YH: The amyloid-beta peptide suppresses transforming growth factor-beta1-induced matrix metalloproteinase-2 production via Smad7 expression in human monocytic THP-1 cells. J Biol Chem 2005, 280:7845–7853.CrossRefPubMed
22.
go back to reference Ryckman C, Vandal K, Rouleau P, Talbot M, Tessier PA: Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J Immunol 2003, 170:3233–3242.CrossRefPubMed Ryckman C, Vandal K, Rouleau P, Talbot M, Tessier PA: Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J Immunol 2003, 170:3233–3242.CrossRefPubMed
23.
go back to reference Chong YH, Sung JH, Shin SA, Chung JH, Suh YH: Effects of the beta-amyloid and carboxyl-terminal fragment of Alzheimer’s amyloid precursor protein on the production of the tumor necrosis factor-alpha and matrix metalloproteinase-9 by human monocytic THP-1. J Biol Chem 2001, 276:23511–23517.CrossRefPubMed Chong YH, Sung JH, Shin SA, Chung JH, Suh YH: Effects of the beta-amyloid and carboxyl-terminal fragment of Alzheimer’s amyloid precursor protein on the production of the tumor necrosis factor-alpha and matrix metalloproteinase-9 by human monocytic THP-1. J Biol Chem 2001, 276:23511–23517.CrossRefPubMed
24.
go back to reference Lee EO, Kim SE, Park HK, Kang JL, Chong YH: Extracellular HIV-1 Tat upregulates TNF-α dependent MCP-1/CCL2 production via activation of ERK1/2 pathway in rat hippocampal slice cultures: inhibition by resveratrol, a polyphenolicphytostilbene. Exp Neurol 2011, 229:399–408.CrossRefPubMed Lee EO, Kim SE, Park HK, Kang JL, Chong YH: Extracellular HIV-1 Tat upregulates TNF-α dependent MCP-1/CCL2 production via activation of ERK1/2 pathway in rat hippocampal slice cultures: inhibition by resveratrol, a polyphenolicphytostilbene. Exp Neurol 2011, 229:399–408.CrossRefPubMed
25.
go back to reference Soscia SJ, Kirby JE, Washicosky KJ, Tucker SM, Ingelsson M, Hyman B, Burton MA, Goldstein LE, Duong S, Tanzi RE, Moir RD: The Alzheimer’s disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS One 2010, 5:e9505.CrossRefPubMedPubMedCentral Soscia SJ, Kirby JE, Washicosky KJ, Tucker SM, Ingelsson M, Hyman B, Burton MA, Goldstein LE, Duong S, Tanzi RE, Moir RD: The Alzheimer’s disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS One 2010, 5:e9505.CrossRefPubMedPubMedCentral
26.
go back to reference Chong YH, Shin YJ, Lee EO, Kayed R, Glabe CG, Tenner AJ: ERK1/2 activation mediates Abeta oligomer-induced neurotoxicity via caspase-3 activation and tau cleavage in rat organotypic hippocampal slice cultures. J Biol Chem 2006, 281:20315–20325.CrossRefPubMed Chong YH, Shin YJ, Lee EO, Kayed R, Glabe CG, Tenner AJ: ERK1/2 activation mediates Abeta oligomer-induced neurotoxicity via caspase-3 activation and tau cleavage in rat organotypic hippocampal slice cultures. J Biol Chem 2006, 281:20315–20325.CrossRefPubMed
27.
go back to reference Malm TM, Koistinaho M, Parepalo M, Vatanen T, Ooka A, Karlsson S, Koistinaho J: Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice. Neurobiol Dis 2005, 18:134–142.CrossRefPubMed Malm TM, Koistinaho M, Parepalo M, Vatanen T, Ooka A, Karlsson S, Koistinaho J: Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice. Neurobiol Dis 2005, 18:134–142.CrossRefPubMed
28.
go back to reference Foell D, Wittkowski H, Vogl T, Roth J: S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J Leukoc Biol 2007, 81:28–37.CrossRefPubMed Foell D, Wittkowski H, Vogl T, Roth J: S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J Leukoc Biol 2007, 81:28–37.CrossRefPubMed
29.
go back to reference Voganatsi A, Panyutich A, Miyasaki KT, Murthy RK: Mechanism of extracellular release of human neutrophil calprotectin complex. J Leukoc Biol 2001, 70:130–134.PubMed Voganatsi A, Panyutich A, Miyasaki KT, Murthy RK: Mechanism of extracellular release of human neutrophil calprotectin complex. J Leukoc Biol 2001, 70:130–134.PubMed
30.
go back to reference Kido J, Hayashi N, Kataoka M, Nagata T: Calprotectin expression in human monocytes:induction by porphyromonasgingivalis lipopolysaccharide, tumor necrosis factor-alpha, and interleukin-1beta. J Periodontol 2005, 76:437–442.CrossRefPubMed Kido J, Hayashi N, Kataoka M, Nagata T: Calprotectin expression in human monocytes:induction by porphyromonasgingivalis lipopolysaccharide, tumor necrosis factor-alpha, and interleukin-1beta. J Periodontol 2005, 76:437–442.CrossRefPubMed
31.
go back to reference Rammes A, Roth J, Goebeler M, Klempt M, Hartmann M, Sorg C: Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J Biol Chem 1997, 272:9496–9502.CrossRefPubMed Rammes A, Roth J, Goebeler M, Klempt M, Hartmann M, Sorg C: Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J Biol Chem 1997, 272:9496–9502.CrossRefPubMed
32.
go back to reference Vogl T, Ludwig S, Goebeler M, Strey A, Thorey IS, Reichelt R, Foell D, Gerke V, Manitz MP, Nacken W, Werner S, Sorg C, Roth J: MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes. Blood 2004, 104:4260–4268.CrossRefPubMed Vogl T, Ludwig S, Goebeler M, Strey A, Thorey IS, Reichelt R, Foell D, Gerke V, Manitz MP, Nacken W, Werner S, Sorg C, Roth J: MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes. Blood 2004, 104:4260–4268.CrossRefPubMed
33.
go back to reference Xu K, Geczy CL: IFN-gamma and TNF regulate macrophage expression of the chemotactic S100 protein S100A8. J Immunol 2000, 164:4916–4923.CrossRefPubMed Xu K, Geczy CL: IFN-gamma and TNF regulate macrophage expression of the chemotactic S100 protein S100A8. J Immunol 2000, 164:4916–4923.CrossRefPubMed
34.
go back to reference Xu K, Yen T, Geczy CL: IL-10 up-regulates macrophage expression of the S100 protein S100A8. J Immunol 2001, 166:6358–6366.CrossRefPubMed Xu K, Yen T, Geczy CL: IL-10 up-regulates macrophage expression of the S100 protein S100A8. J Immunol 2001, 166:6358–6366.CrossRefPubMed
35.
go back to reference Bréchard S, Plançon S, Tschirhart EJ: New insights into the regulation of neutrophil NADPH oxidase activity in the phagosome: a focus on the role of lipid and Ca(2+) signaling. Antioxid Redox Signal 2013, 18:661–676.CrossRefPubMedPubMedCentral Bréchard S, Plançon S, Tschirhart EJ: New insights into the regulation of neutrophil NADPH oxidase activity in the phagosome: a focus on the role of lipid and Ca(2+) signaling. Antioxid Redox Signal 2013, 18:661–676.CrossRefPubMedPubMedCentral
37.
go back to reference Demuro A, Smith M, Parker I: Single-channel Ca(2+) imaging implicates Aβ1–42 amyloid pores in Alzheimer’s disease pathology. J Cell Biol 2011, 195:515–524.CrossRefPubMedPubMedCentral Demuro A, Smith M, Parker I: Single-channel Ca(2+) imaging implicates Aβ1–42 amyloid pores in Alzheimer’s disease pathology. J Cell Biol 2011, 195:515–524.CrossRefPubMedPubMedCentral
38.
go back to reference Camandola S, Mattson MP: Aberrant subcellular neuronal calcium regulation in aging and Alzheimer’s disease. Biochim Biophys Acta 2011, 1813:965–973.CrossRefPubMed Camandola S, Mattson MP: Aberrant subcellular neuronal calcium regulation in aging and Alzheimer’s disease. Biochim Biophys Acta 2011, 1813:965–973.CrossRefPubMed
39.
go back to reference Ladiwala AR, Litt J, Kane RS, Aucoin DS, Smith SO, Ranjan S, Davis J, Van Nostrand WE, Tessier PM: Conformational differences between two amyloid β oligomers of similar size and dissimilar toxicity. J Biol Chem 2012, 287:24765–24773.CrossRefPubMedPubMedCentral Ladiwala AR, Litt J, Kane RS, Aucoin DS, Smith SO, Ranjan S, Davis J, Van Nostrand WE, Tessier PM: Conformational differences between two amyloid β oligomers of similar size and dissimilar toxicity. J Biol Chem 2012, 287:24765–24773.CrossRefPubMedPubMedCentral
40.
go back to reference Medzhitov R: Recognition of microorganisms and activation of the immune response. Nature 2007, 449:819–826.CrossRefPubMed Medzhitov R: Recognition of microorganisms and activation of the immune response. Nature 2007, 449:819–826.CrossRefPubMed
41.
go back to reference Striz I, Trebichavsky I: Calprotectin – a pleiotropic molecule in acute and chronic inflammation. Physiol Res 2004, 53:245–253.PubMed Striz I, Trebichavsky I: Calprotectin – a pleiotropic molecule in acute and chronic inflammation. Physiol Res 2004, 53:245–253.PubMed
42.
go back to reference Swangchan-Uthai T, Lavender CR, Cheng Z, Fouladi-Nashta AA, Wathes DC: Time course of defense mechanisms in bovine endometrium in response to lipopolysaccharide. Biol Reprod 2012, 87:135.CrossRefPubMed Swangchan-Uthai T, Lavender CR, Cheng Z, Fouladi-Nashta AA, Wathes DC: Time course of defense mechanisms in bovine endometrium in response to lipopolysaccharide. Biol Reprod 2012, 87:135.CrossRefPubMed
43.
go back to reference Kagan BL, Jang H, Capone R, TeranArce F, Ramachandran S, Lal R, Nussinov R: Antimicrobial properties of amyloid peptides. Mol Pharm 2012, 9:708–717.CrossRefPubMed Kagan BL, Jang H, Capone R, TeranArce F, Ramachandran S, Lal R, Nussinov R: Antimicrobial properties of amyloid peptides. Mol Pharm 2012, 9:708–717.CrossRefPubMed
44.
go back to reference Honjo K, van Reekum R, Verhoeff NP: Alzheimer’s disease and infection: do infectious agents contribute to progression of Alzheimer’s disease? Alzheimers Dement 2009, 5:348–360.CrossRefPubMed Honjo K, van Reekum R, Verhoeff NP: Alzheimer’s disease and infection: do infectious agents contribute to progression of Alzheimer’s disease? Alzheimers Dement 2009, 5:348–360.CrossRefPubMed
45.
go back to reference Itzhaki RF, Wozniak MA, Appelt DM, Balin BJ: Infiltration of the brain by pathogens causes Alzheimer’s disease. Neurobiol Aging 2004, 25:619–627.CrossRefPubMed Itzhaki RF, Wozniak MA, Appelt DM, Balin BJ: Infiltration of the brain by pathogens causes Alzheimer’s disease. Neurobiol Aging 2004, 25:619–627.CrossRefPubMed
46.
47.
48.
go back to reference Miklossy J: Alzheimer’s disease - a neurospirochetosis. Analysis of the evidence following Koch’s and Hill’s criteria. J Neuroinflammation 2011, 8:90.CrossRefPubMedPubMedCentral Miklossy J: Alzheimer’s disease - a neurospirochetosis. Analysis of the evidence following Koch’s and Hill’s criteria. J Neuroinflammation 2011, 8:90.CrossRefPubMedPubMedCentral
Metadata
Title
Amyloid-β peptide-induced extracellular S100A9 depletion is associated with decrease of antimicrobial peptide activity in human THP-1 monocytes
Authors
Eun Ok Lee
Ji Hye Yang
Keun-A Chang
Yoo-Hun Suh
Young Hae Chong
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Journal of Neuroinflammation / Issue 1/2013
Electronic ISSN: 1742-2094
DOI
https://doi.org/10.1186/1742-2094-10-68

Other articles of this Issue 1/2013

Journal of Neuroinflammation 1/2013 Go to the issue